Skip to main content
  • Home
  •  Heart Failure Online 2022 - Session 2.5 Practical Theory & Hot Topics: Advanced HF Care

Heart Failure Online 2022 - Session 2.5 Practical Theory & Hot Topics: Advanced HF Care

Topic:
  • Heart Failure

Available Credit:

  • 1.00 EBAC

Course Published On:

Course Expiry Date:

HFO 2022 - Session 2.5 Practical Theory & Hot Topics: Advanced HF Care
No ratings

Overview

Heart Failure Online (HFO) is a new innovative virtual event, that brings together a leading international faculty to create a rich, interactive experience to best inform the global heart failure community of the latest developments and advances in clinical practice.

With patient management and outcomes at its core, Course Director Prof Andrew Coats (President of the Heart Failure Association and Professor of Cardiology, University of Warwick, UK) leads an interactive programme of discussion, opinion and case studies focusing on the patient journey.

Disclosure

In compliance with EBAC / EACCME guidelines, all speakers/chairpersons participating in this programme have disclosed or indicated potential conflicts of interest which might cause a bias in the presentations.

 

The Organising Committee/Course Director is responsible for ensuring that all potential conflicts of interest relevant to the event are declared to the audience prior to the CME activities.

Terms & Conditions

Radcliffe Education requires contributors to our CME programmes to disclose any relevant financial relationships that have occurred within the past 12 months that could create a conflict of interest. These will be identified in the faculty section if applicable.

 

The session 'Heart Failure Online 2022 - Session 2.5 Practical Theory & Hot Topics: Advanced HF Care' is accredited by the European Board for Accreditation of Continuing Education for Health Professionals (EBAC) for 1 hour of external CME credits.

 

Each participant should claim only those hours of credit that have actually been spent in the educational activity. EBAC works according to the quality standards of the European Accreditation Council for Continuing Medical Education (EACCME), which is an institution of the European Union of Medical Specialists (UEMS).

 

Through an agreement between the European Board for  Accreditation of Continuing Education for Health Professionals (EBAC) and the American Medical Association, physicians may convert EBAC External CME credits to AMA PRA Category 1 Credits™. Information on the process to convert EBAC credit to AMA credit can be found on the AMA website.

Instructions to Participants

There is no fee for taking part in this online learning activity.

 

Activities are designed to be completed within 60 minutes and must be completed by the registered user. Physicians should only claim credits for time spent on the activity. To successfully earn credit, participants must complete the activity in full in the indicated time frame.

 

To complete the course and claim certification participants must:

  • Read the course outline information supplied and complete pre-test questions if supplied prior to starting the activity. Users must read and study the activity in its entirety before completing the post-test questions.
  • Your results will be automatically saved and if a pass score is achieved (where applicable), you may be eligible to claim credit for the activity and receive a certificate of completion.

Target Audience

  • Heart Failure Specialists
  • General Cardiologists
  • General Practitioners (GPs)
  • Nurses, Pharmacists, and other Allied Healthcare Professionals

Learning Objectives

The overall programme, Heart Failure Online 2022, endeavours to best address the following learning objectives:

  • Select foundational and advanced management strategies in complex patients
  • Discuss the validity of using ejection fraction to determine optimal treatment strategies
  • Assess the likely impact of health technology on future practice
  • Identify the underlying causes of heart failure
  • Select appropriate interventional and device-based treatments for treating underlying causes of heart failure
  • Assess the impact of the multidisciplinary team on heart failure outcomes
  • Discuss the importance of using quality of life and patient self-assessed measures relative to hard clinical end points

Module

Title

Duration

Speakers

Presentation & Discussion Triaging of Patients with Advanced Heart Failure: Mechanical Assistance or Transplant? A US vs European View 15 mins Shelley A Hall (Dallas, US ) Maria Generosa Crespo-Leiro (La Coruna, ES )
Presentation & Discussion MCS Considerations: Compliance and Psychosocial Support 15 mins Alanna Morris (Georgia, US )
Presentation & Discussion Cardiopulmonary Exercise Testing in Advanced Patients 15 mins Massimo Piepoli (Piacenza, IT)
Presentation & Discussion Improving Outcomes Post-transplantation 15 mins Joyce W. Wald (Philadelphia, US )
Presentation & Discussion.

Triaging of Patients with Advanced Heart Failure: Mechanical Assistance or Transplant? A US vs European View

Duration: 15 mins

Speakers: Shelley A Hall (Dallas, US ) Maria Generosa Crespo-Leiro (La Coruna, ES )

Presentation & Discussion.

MCS Considerations: Compliance and Psychosocial Support

Duration: 15 mins

Speakers: Alanna Morris (Georgia, US )

Presentation & Discussion.

Cardiopulmonary Exercise Testing in Advanced Patients

Duration: 15 mins

Speakers: Massimo Piepoli (Piacenza, IT)

Presentation & Discussion.

Improving Outcomes Post-transplantation

Duration: 15 mins

Speakers: Joyce W. Wald (Philadelphia, US )

Chair

Ileana L Piña

Wayne State University, Detroit, MI, US

Dr Ileana L Pina is Professor at the Department of Medicine (Cardiology) and Professor in the Department of Epidemiology and Population Health at Montefiore Einstein Center for Heart and Vascular Care, US. 

View full profile

Panelist

Shelley A Hall

Baylor University Medical Center, Dallas, TX; Texas A&M Health Science Center, College of Medicine, Dallas, TX

Dr Shelley Hall is Chief of Transplant Cardiology and Mechanical Support/Heart Failure, Baylor University Medical Center, US. Dr Hall's particular focus is advanced heart failure and cardiac transplant.

View full profile

Maria Generosa Crespo-Leiro

Complexo Hospitalario Universitario A Coruña (CHUAC), CIBERCV, Instituto de Investigacion Biomedica A Coruña (INIBIC), Universidad de a Coruña (UDC), La Coruña, Spain

View full profile

Alanna Morris

Dr Alanna Morris is Assistant Professor of Medicine at the Department of Medicine, Emory University School of Medicine, US.

View full profile

Massimo Piepoli

University of Milan, Milan, IT

Prof Massimo Piepoli is the Director of Clinical Cardiology Unit at University of Milan, Milan, IT.

Prof Piepoli is also a Teaching Professor at the Fondazione Monasterio and Scuola Superiore Sant'Anna in Pisa.

View full profile

Joyce W. Wald

Dr Joyce W Wald is a cardiologist in Philadelphia, Pennsylvania, US, and is affiliated with multiple hospitals in the area, including Good Shepherd Penn Partners Speciality Hospital at Rittenhouse and Hospitals of the University of Pennsylvania-Penn Presbyterian.

View full profile
1.00 EBAC

Related Courses

A Race Against Time: Accelerating the Adoption of GDMT in Heart Failure
  • Not accredited

Learning objectives

  • Recall guideline recommendations for the use of NT-proBNP in heart failure
  • Describe current practices in heart failure diagnosis and the impact on treatment outcomes
  • Develop an optimised approach to the timely diagnosis and management of heart failure
See more
Implementing Heart Failure Guidelines with Collaborative Care
  • Not accredited

Learning objectives

  • Appraise new updates in heart failure guideline-directed medical therapy (GDMT)
  • Apply latest guideline recommendations to patient cases
  • Describe barriers preventing early initiation of GDMT
  • Identify the roles of nurses and other healthcare professionals to achieve optimal heart failure therapy
  • Identify the importance of the nurse/cross-functional team
See more
The Advancing Management of Transthyretin Amyloidosis
  • 1.00 EBAC

Learning objectives

  • To differentiate ATTR phenotypes based on presenting signs and symptoms.
  • To select appropriate tests to monitor symptomatic ATTR-cm from imaging, biomarker, functional and QoL assessments.
  • To recall how to identify disease progression across ATTR-cm.
  • To describe the different disease modifying treatments for ATTR including novel agents.
See more
Overcoming the Challenges in Optimising GDMT in HF
  • Not accredited

Learning objectives

  • Appraise the urgency needed in rapid initiation of GDMT to improve HF outcomes.
  • Recognise barriers preventing the use of GDMT in current practice.
  • Identify strategies needed to drive implementation of GDMT in clinical practice.
See more
Hyperkalaemia in Cardiorenal Disease – A Case Based Discussion
  • Not accredited

Learning objectives

  • Explain the relationship between sub-optimal RAASi therapy and poor cardio-renal outcomes
  • Identify patients who would benefit from anti-hyperkalaemia medications
  • Select appropriate anti-hyperkalaemia treatments across a range of patient profiles
  • Adopt anti-hyperkalaemia medications as an approach to prolong optimal RAASi therapy
  • Summarise current guideline recommendations on the use of potassium binding agents
See more
Examining a Complex Heart Failure Case
  • 1.00 EBAC

Learning objectives

  • Identify individuals likely to have HFpEF from initial presentation
  • Refer suspected individuals for specialist assessment
  • Initiate GDMT for HF as soon as patients are stable 
  • Initiate GDMT in HF regardless of EF and phenotype
  • Initiate shared decision-making on complex HF patients with other members of the multidisciplinary team including cardiologists, GPs, nephrologists and diabetologists
See more
Obstructive Hypertrophic Cardiomyopathy: Getting It Right First Time
  • 1.00 EBAC

Learning objectives

  • Recall the general approach to diagnosis and stratification of HCM according to the latest guidelines and expert opinion
  • Apply advanced echocardiographic methodologies to equivocal HCM diagnoses
  • Select appropriate imaging modalities to facilitate accurate risk stratification
  • Stratify patients based on specific risk features and disease severity
  • Choose suitable treatment modalities for patients based on specific disease features and severity
See more
Incorporating GDMT and PRO Endpoints for Personalised HF Management
  • 1.00 EBAC

Learning objectives

  • Review current GDMT in HFrEF and HFpEF
  • Describe the relationship between initiation of GDMT and HF outcomes
  • Prescribe GDMT according to current international recommendations
  • Recall the elements of the Kansas City Cardiomyopathy Questionnaire
  • Describe the clinical studies that support the use of functional and QoL measures in practice
  • Initiate quality of life and functional improvement measures in routine practice
  • Initiate SGLT-2 inhibitors in patients presenting with De novo HF and in patients already on other GDMT
  • Adopt shared decision-making with HF patients
See more
Changing Paradigms in Therapy to Unmet Needs
  • 1.00 EBAC

Learning objectives

  • Recall the utility of EF in heart failure treatment, patient selection and treatment response 
  • Identify alternative measures to EF for the purposes HF severity and therapeutic efficacy 
  • Incorporate quality of life measures for assessing therapeutic efficacy in HF 
  • Recall outcomes from heart failure trials from recent congress and publications and their impact on practice 
See more
SGLT-2 Inhibitors - Another Piece of the Puzzle in Heart Failure
  • 1.00 EBAC

Learning objectives

  • Recall the results of key trials in HFmrEF in different patients' sub-groups
  • Describe how SGLT-2 inhibitors can be used across the range of LVEF
  • Apply emerging diagnostic approaches for HFpEF and HFmrEF
  • Implement best-practice strategies across the range of LVEF
See more